Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial

The Lancet ◽  
2016 ◽  
Vol 387 (10013) ◽  
pp. 40-52 ◽  
Author(s):  
Diamant Thaçi ◽  
Eric L Simpson ◽  
Lisa A Beck ◽  
Thomas Bieber ◽  
Andrew Blauvelt ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Severe Atopic Dermatitis ◽  
Efficacy And Safety ◽  
Dose Ranging ◽  
Topical Treatments

scholarly journals A Phase 2b Dose-Ranging Efficacy and Safety Study of Tralokinumab in Adult Patients with Moderate to Severe Atopic Dermatitis

2018 ◽  
Vol 2 ◽  
pp. S29 ◽  
Author(s):  
Andreas Wollenberg ◽  
Michael D Howell ◽  
Emma Guttman-Yassky ◽  
Jonathan I Silverberg ◽  
Claire Birrell ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Adult Patients ◽  
Severe Atopic Dermatitis ◽  
Efficacy And Safety ◽  
Safety Study ◽  
Dose Ranging

Abstract not available. Disclosures: Study sponsored by LEO Pharma Copyright 2018 SKIN

scholarly journals Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis

2020 ◽  
Vol 156 (8) ◽  
pp. 863 ◽  
Author(s):  
Jonathan I. Silverberg ◽  
Eric L. Simpson ◽  
Jacob P. Thyssen ◽  
Melinda Gooderham ◽  
Gary Chan ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Severe Atopic Dermatitis ◽  
Efficacy And Safety
Sign in / Sign up

Export Citation Format

Share Document